| Literature DB >> 30451871 |
Jens Gempt1, Stefanie Bette2, Jennifer Albertshauser3, Jasmin Hernandez Cammardella3, Corinna Gradtke3, Benedikt Wiestler2, Lucas Schirmer4,5, Yu-Mi Ryang3, Bernhard Meyer3, Florian Ringel3,6.
Abstract
Aim of this study was to analyze personality traits in patients with neuroepithelial brain tumors. Personality alteration is a common feature in brain tumor patients, but not much is known about associations between specific personality changes and brain tumors. We assessed potential factors influencing personality such as tumor location, tumor grade and tumor volume. Mini-mental state examination (MMSE), Beck's Depression Inventory II (BDI-II), and the NEO Five-Factor Inventory (NEO-FFI) for the five factors of personality were acquired. Patients had lower scores regarding the factor openness and higher scores regarding the BDI-II compared to the norm population. No significant influencing factors (tumor entity, location) were found regarding personality traits. Neuroticism was associated with depression, whereas extraversion showed an opposed association. Patients with intrinsic brain tumors have differences in personality traits compared to the control population, with an emphasis on the factor openness. No significant confounding factors like tumor grade, entity, or location were found for personality traits.Entities:
Mesh:
Year: 2018 PMID: 30451871 PMCID: PMC6243000 DOI: 10.1038/s41598-018-34980-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Patient and tumor characteristics at different time points (non-normally distributed data shown as median (interquartile range); DNET: dysembryoplastic neuroepithelial tumor).
| t0 | t1 | |
|---|---|---|
| n | 73 | 45 |
| age | 48.8y (−/+17.6) | 43.1y (−/+16.1) |
| sex, female | 36/73 (49.3%) | 20/45 (44.4%) |
| WHO grade I | 17/73 (23.3%) | 12/45 (26.7%) |
| - pineocytoma | 10/17 | 7/12 |
| - pilocytic astrocytoma | 1/17 | 1/12 |
| - ganglioglioma | 3/17 | 2/12 |
| - DNET | 2/17 | 2/12 |
| WHO grade II | 14/73 (19.2%) | 10/45 (22.2%) |
| - diffuse astrocytoma | 8/14 | 6/10 |
| - oligoastrocytoma | 2/14 | 2/10 |
| - oligodendroglioma | 3/14 | 2/10 |
| - neurocytoma | 1/14 | — |
| WHO grade III | 10/73 (13.7%) | 8/45 (17.8%) |
| - anapl. Astrocytoma | 6/10 | 4/8 |
| - anapl. Oligoastrocytoma | 3/10 | 3/8 |
| - anapl. oligodendroglioma | 1/10 | 1/8 |
| WHO grade IV | 32/73 (43.8%) | 15/45 (33.3%) |
| - glioblastoma | 31/32 | 15/15 |
| - medulloblastoma | 1/32 | — |
|
| ||
| - T2 FLAIR (cm3) | 16.3 (1.9–38.8) | 13.9 (1.6–39.1) |
| - T1 contrast (cm3) | 1.0 (0.0–22.3) | 0.6 (0.0–10.5) |
|
| ||
| - T2 FLAIR (cm3) | 1.0 (0.0–9.9) | 0.1 (0.0–5.1) |
| - T1 contrast (cm3) | 0.0 (0.0–0.4) | 0.0 (0.0–0.0) |
|
| ||
| - frontal | 21/73 | 11/45 |
| - parietal | 2/73 | 1/45 |
| - temporal | 14/73 | 9/45 |
| - infratentorial | 3/73 | 1/45 |
| - midline | 9/73 | 7/45 |
| - multilobular without midline | 17/73 | 15/45 |
| - multilobular with midline | 4/73 | 1/45 |
| - ventricle | 3/73 | — |
|
| ||
| - right | 30/73 | 22/45 |
| - left | 25/73 | 15/45 |
| - midline | 12/73 | 7/45 |
| - both | 6/73 | 1/45 |
|
| ||
| - neuroticism | 20.0 (15.0–24.0) | 20.0 (13.0–23.5) |
| - extraversion | 28.0 (23.0–33.0) | 29.0 (23.5–33.5) |
| - openness | 27.0 (24.0–32.5) | 26.0 (22.5–32.5) |
| - agreeableness | 31.0 (29.0–35.0) | 31.0 (27.5–35.0) |
| - conscientiousness | 34.0 (30.5–37.0) | 31.0 (28.5–38.5) |
|
| ||
| - BDI-II | 8.0 (5.0–13.5) | 7.0 (4.0–10.0) |
Figure 1Mean values and standard deviation of scores for the five personality traits Neuroticism (A), Extraversion (B), Openness (C), Agreeableness (D), and Conscientiousness (E) compared to the mean of the normal population (-----).
Factors associated with personality traits: Neuroticism (A), Extraversion (B), Openness (C), Agreeableness (D), and Conscientiousness (E).
| Feature | test | t0 (n = 73) |
|---|---|---|
|
| ||
| WHO grade | Kruskal-Wallis | n.s. |
| Hemisphere | Kruskal-Wallis | n.s. |
| Tumor entity | Kruskal-Wallis | n.s. |
| Tumor location | Kruskal-Wallis | n.s. |
| Tumor volume (T1 contrast) | Spearman | n.s. |
| r = 0.072 | ||
| Tumor volume (T2 FLAIR) | Spearman | n.s. |
| r = −0.023 | ||
| BDI-II | Spearman | |
| r = 0.496 | ||
|
| ||
| WHO grade | Kruskal-Wallis | n.s. |
| Hemisphere | Kruskal-Wallis | n.s. |
| Tumor entity | Kruskal-Wallis | n.s. |
| Tumor location | Kruskal-Wallis | n.s. |
| Tumor volume (T1 contrast) | Spearman | n.s. |
| r = 0.072 | ||
| Tumor volume (T2 FLAIR) | Spearman | n.s. |
| r = −0.023 | ||
| BDI-II | Spearman | |
| r = −0.413 | ||
|
| ||
| WHO grade | Kruskal-Wallis | n.s. |
| Hemisphere | Kruskal-Wallis | n.s. |
| Tumor entity | Kruskal-Wallis | n.s. |
| Tumor location | Kruskal-Wallis | n.s. |
| Tumor volume (T1 contrast) | Spearman | n.s. |
| r = 0.072 | ||
| Tumor volume (T2 FLAIR) | Spearman | n.s. |
| r = −0.023 | ||
| BDI-II | Spearman | n.s. |
| r = −0.071 | ||
|
| ||
| WHO grade | Kruskal-Wallis | n.s. |
| Hemisphere | Kruskal-Wallis | n.s. |
| Tumor entity | Kruskal-Wallis | n.s. |
| Tumor location | Kruskal-Wallis | n.s. |
| Tumor volume (T1 contrast) | Spearman | n.s. |
| r = 0.072 | ||
| Tumor volume (T2 FLAIR) | Spearman | n.s. |
| r = −0.023 | ||
| BDI-II | Spearman | n.s. |
| r = −0.120 | ||
|
| ||
| WHO grade | Kruskal-Wallis | n.s. |
| Hemisphere | Kruskal-Wallis | n.s. |
| Tumor entity | Kruskal-Wallis | n.s. |
| Tumor location | Kruskal-Wallis | n.s. |
| Tumor volume (T1 contrast) | Spearman | n.s. |
| r = 0.072 | ||
| Tumor volume (T2 FLAIR) | Spearman | n.s. |
| r = −0.023 | ||
| BDI-II | Spearman | n.s. |
| r = −0.297 | ||
|
| ||
| WHO grade | Kruskal-Wallis | n.s. |
| Hemisphere | Kruskal-Wallis | n.s. |
| Tumor entity | Kruskal-Wallis | n.s. |
| Tumor location | Kruskal-Wallis | n.s. |
| Tumor volume (T1 contrast) | Spearman | n.s. |
| r = −0.079 | ||
| Tumor volume (T2 FLAIR) | Spearman | n.s. |
| r = −0.107 | ||
Figure 2Correlation between BDI-II and the personality traits neuroticism and extraversion.